- Tim Cook Chairman and CEO
- President and COO (To be announced)
- Tom Cleary, Chief Medical Officer
Timothy E. Cook, CIF
Chief Executive Officer and Board Chairman
Mr. Cook holds a Bachelors Degree in Business from Marian
College, Indianapolis, Indiana. He has 20+ years of accelerated
experience in institutional size global investments in the
form of structured transactions involving customized fixed
income products and related derivatives. Mr. Cook was CEO
and CFO from 1985 to 2000 with SUISSECAP, Inc. a Financial
Engineering Firm. Mr. Cook also held the positions of Chief
Investment Strategist over International Operations and Global
Operations Director. His duties were to plan, direct and manage
all aspects of the firm. More specifically he was involved
in identifying new technologies worldwide and assisting in
bringing the companies to the public market. He was responsible
for the analysis of each companies financial statement, which
included complex domestic and foreign monetary transactions
in a number of currencies. Mr. Cook was responsible for Risk
Management and Evaluation of New Technologies; and his areas
of concentration were in Bio-Medical Technology / Advanced
Medicine and Alternative Energy.
Mr. Cook has extensive knowledge of all procedures and SEC
rules and regulations associated with taking a company from
a private status to the public market; and he holds a License
and Certification as a Certified International Financier.
For the past 5 years Mr. Cook has concentrated on bringing
XYTOS' next generation Bio-Medical Technologies in the areas
of Stem Cell Therapy, Tissue Engineering and Cellular Medicine
to the Global Medical Community and transforming XYTOS into
a Publicly Listed Company.
Mr. Cook has an extensive background in Marketing, Public
Relations and Investors Relations and he brings to the company
a tremendous amount of experience as it relates to running
a public company. Mr. Cook has combined his Financial Background
and Global Contacts with his knowledge of Specific Advanced
Medicines in an effort to ensure that XYTOS becomes a Global
leader in the Introduction of Next Generation Medicine and
Medical Procedures.
President / Chief Operation Officer
XYTOS will make a public announcement with respect to this
position and then post the CV on this website for review.
Thomas M Cleary MD, LAH Dubl, MB, BCh, and NUI
Chief Medical Officer
Dr. Cleary, a licensed physician, has been practicing medicine
for over 30 years. Trained in Dublin, Ireland and number of
universities worldwide he holds the qualifications LAH Dubl,
MB, BCh, and NUI. Dr. Cleary is a registered medical doctor
authorized to practice anywhere within the British Commonwealth
and Europe. Dr. Cleary is a Licensed Pharmacist within Europe
and is a European qualified person - regulatory. Dr. Cleary
has had many senior positions in the pharmaceutical industry
and finds his background in pharmacology very useful for developing
improved XPDT protocols for XYTOS. Dr. Cleary has wide commercial
experience and has been Chairman of several very well known
Health related organizations and has chaired three pharmaceutical
companies. Dr. Cleary is our senior physician and he has been
treating cancer patients with XPDT (the XYTOS Alternative
Cancer Treatment) using our next generation protocol since
2002.
|
